Tatva Chintan Pharma Chem Limited
NSE:TATVA.NS
856.35 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 382.92 | 273.66 | 630.17 | 44.81 | 101.56 | 151 | 77.6 |
| Short Term Investments
| 137.41 | 206.42 | 1,105.24 | 8.43 | 10.92 | 85.4 | 13.38 |
| Cash and Short Term Investments
| 483.43 | 480.08 | 1,735.41 | 44.81 | 101.56 | 151 | 90.98 |
| Net Receivables
| 700.93 | 849.46 | 584.27 | 907.43 | 495.71 | 635.94 | 321.46 |
| Inventory
| 1,527.66 | 1,624.98 | 1,699.58 | 720.19 | 635.55 | 355.9 | 289.8 |
| Other Current Assets
| 267.04 | 129.32 | 4.21 | 21.27 | 76.52 | 1 | 62.82 |
| Total Current Assets
| 2,979.06 | 3,135.55 | 4,358.85 | 1,842.5 | 1,326.99 | 1,143.84 | 765.06 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 4,994.62 | 4,265.15 | 2,107.87 | 1,301.62 | 1,159.52 | 726.1 | 670.82 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 39.61 | 4.76 | 3.17 | 0.95 | 1.2 | 1.38 | 1.28 |
| Goodwill and Intangible Assets
| 39.61 | 4.76 | 3.17 | 0.95 | 1.2 | 1.38 | 1.28 |
| Long Term Investments
| 42.6 | -177.95 | -1,152.37 | 1,232.78 | 1,148.92 | -1.46 | -2.28 |
| Tax Assets
| 122.97 | 123.56 | 87.1 | 72.75 | 13.47 | 1.46 | 6.88 |
| Other Non-Current Assets
| 8.32 | 211.93 | 1,178.39 | -1,302.57 | -1,160.72 | 3.76 | 2.28 |
| Total Non-Current Assets
| 5,208.12 | 4,427.45 | 2,224.16 | 1,305.53 | 1,162.39 | 731.24 | 678.98 |
| Total Assets
| 8,187.18 | 7,563 | 6,583.01 | 3,148.03 | 2,489.38 | 1,875.08 | 1,444.04 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 450.31 | 321.88 | 445.13 | 474.77 | 316.13 | 221.34 | 247.03 |
| Short Term Debt
| 136.32 | 1,660.27 | 1,068.27 | 634.85 | 519.8 | 456.29 | 359.87 |
| Tax Payables
| 0.76 | 2.13 | 10.23 | 6.88 | 0 | 0 | 0.2 |
| Deferred Revenue
| 0.76 | 302.54 | 15.53 | -634.85 | -543.89 | -449.83 | 0.48 |
| Other Current Liabilities
| 209.24 | 76.65 | 185.4 | 705.38 | 584.46 | 498.72 | 19.31 |
| Total Current Liabilities
| 796.63 | 2,361.34 | 1,714.33 | 1,180.15 | 876.5 | 726.52 | 626.69 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 6.39 | 42.3 | 131.11 | 267.63 | 387.09 | 315.19 | 201.59 |
| Deferred Revenue Non-Current
| -271.41 | -72.86 | 0.17 | 0.17 | 0.26 | 0.35 | -0 |
| Deferred Tax Liabilities Non-Current
| 271.41 | 126.61 | 6.34 | 20.78 | 44.55 | 33.08 | 23.02 |
| Other Non-Current Liabilities
| 13.34 | -42.3 | 0.17 | 19.66 | 4.04 | 2.94 | 1.18 |
| Total Non-Current Liabilities
| 19.73 | 53.75 | 137.79 | 308.24 | 435.94 | 351.56 | 225.79 |
| Total Liabilities
| 816.36 | 2,415.09 | 1,852.12 | 1,488.39 | 1,312.44 | 1,078.08 | 852.48 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 796.56 | 0 |
| Common Stock
| 233.92 | 221.65 | 221.65 | 200.88 | 80.35 | 80.35 | 80.35 |
| Retained Earnings
| 3,081.99 | 2,825.25 | 2,414.71 | 1,456.02 | 1,094.1 | 716.21 | 510.78 |
| Accumulated Other Comprehensive Income/Loss
| 7,136.9 | 10.75 | 4.27 | 2.74 | 2.48 | 0.44 | -0.01 |
| Other Total Stockholders Equity
| -3,081.99 | 2,090.26 | 2,090.26 | 0 | 0.01 | -796.56 | 0 |
| Total Shareholders Equity
| 7,370.82 | 5,147.91 | 4,730.89 | 1,659.64 | 1,176.94 | 797 | 591.12 |
| Total Equity
| 7,370.82 | 5,147.91 | 4,730.89 | 1,659.64 | 1,176.94 | 797 | 591.12 |
| Total Liabilities & Shareholders Equity
| 8,187.18 | 7,563 | 6,583.01 | 3,148.03 | 2,489.38 | 1,875.08 | 1,444.04 |